+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Gilead Sciences Inc - logo

Founded in 1987 Gilead Sciences is a biopharmaceutical company focused on developing innovative treatments for life threatening illnesses. Their areas of research include HIV/AIDs, Liver Diseases, Hematology, Oncology, Cardiovascular and Respiratory disease. Gilead Sciences is based in California, USA and their product portfolio consists of well-known treatments like Atripla, Sovaldi, Zydelig, Viread and many more.

Automation in Biopharma Industry Report 2023-2033 - Product Thumbnail Image

Automation in Biopharma Industry Report 2023-2033

  • Report
  • March 2023
  • 396 Pages
  • Global
From
Vasculitis Treatment - Global Strategic Business Report - Product Thumbnail Image

Vasculitis Treatment - Global Strategic Business Report

  • Report
  • November 2025
  • 183 Pages
  • Global
From
Myasthenia Gravis Treatment Market: Forecast and Trends - Product Thumbnail Image

Myasthenia Gravis Treatment Market: Forecast and Trends

  • Report
  • November 2023
  • 120 Pages
  • Global
From
From
Non-alcoholic Steatohepatitis (NASH) Market 2024-2028 - Product Thumbnail Image

Non-alcoholic Steatohepatitis (NASH) Market 2024-2028

  • Report
  • August 2024
  • 154 Pages
  • Global
From
From
Regenerative Medicine Market Report 2023-2033 - Product Thumbnail Image

Regenerative Medicine Market Report 2023-2033

  • Report
  • March 2023
  • 232 Pages
  • Global
From
From
From
HIV Injections Market - Global Strategic Business Report - Product Thumbnail Image

HIV Injections Market - Global Strategic Business Report

  • Report
  • November 2025
  • 182 Pages
  • Global
From
Liver Cirrhosis Therapeutics Market 2024-2028 - Product Thumbnail Image

Liver Cirrhosis Therapeutics Market 2024-2028

  • Report
  • November 2023
  • 154 Pages
  • Global
From
Thyroid Cancer Drugs Market Report 2025 - Product Thumbnail Image

Thyroid Cancer Drugs Market Report 2025

  • Report
  • September 2025
  • 250 Pages
  • Global
From
From
Loading Indicator